Want to see MWAI full AI Analyst Report?
MedWellAI (MWAI) Ratios
MedWellAI Ratios
MWAI's free cash flow for Q4 2026 was $-136.25K. For the 2026 fiscal year, MWAI's free cash flow was increased by $0.00 and operating cash flow was $-136.25K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.14 | 0.71 | 0.09 | 0.32 |
| Quick Ratio | 0.01 | 0.14 | 0.71 | 0.09 | 0.32 |
| Cash Ratio | 0.01 | 0.13 | 0.02 | 0.09 | 0.31 |
| Solvency Ratio | -0.20 | -1.14 | -1.11 | -1.12 | 0.18 |
| Operating Cash Flow Ratio | -0.04 | -0.31 | -1.12 | -1.15 | 0.04 |
| Short-Term Operating Cash Flow Coverage | -0.61 | -1.78 | -8.26 | -6.86 | 0.14 |
| Net Current Asset Value | $ -7.85M | $ -2.72M | $ -5.21M | $ -6.84M | $ -5.20M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 3.56 | 0.75 | 0.13 | 0.08 | 0.02 |
| Debt-to-Equity Ratio | -0.06 | -0.24 | -0.13 | -0.98 | 0.04 |
| Debt-to-Capital Ratio | -0.07 | -0.32 | -0.15 | -50.59 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.02 | -0.32 | -1.02 | -12.93 | 1.54 |
| Debt Service Coverage Ratio | -2.23 | -4.95 | -14.76 | -27.78 | 2.65 |
| Interest Coverage Ratio | -23.63 | -54.38 | -137.77 | -36.76 | -1005.01 |
| Debt to Market Cap | 0.28 | 0.30 | 0.12 | 0.08 | 0.05 |
| Interest Debt Per Share | 0.09 | 0.12 | 0.13 | 0.35 | 0.25 |
| Net Debt to EBITDA | -0.36 | -0.07 | -0.05 | -0.01 | -0.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 94.12% | 98.64% | 32.97% | 32.97% | 30.10% |
| EBIT Margin | -226.87% | -487.16% | -195.11% | -429.46% | -14.17% |
| EBITDA Margin | -220.42% | -481.79% | -146.76% | -368.11% | 27.69% |
| Operating Profit Margin | -234.25% | -477.59% | -195.11% | -173.63% | -475.83% |
| Pretax Profit Margin | -287.95% | -495.94% | -196.53% | -196.53% | -659.10% |
| Net Profit Margin | -301.12% | -606.48% | -196.53% | -196.53% | -14.64% |
| Continuous Operations Profit Margin | -301.12% | -495.94% | -196.53% | -196.53% | -14.64% |
| Net Income Per EBT | 104.57% | 122.29% | 100.00% | 100.00% | 2.22% |
| EBT Per EBIT | 122.93% | 103.84% | 100.73% | 113.19% | 138.52% |
| Return on Assets (ROA) | -1131.72% | -447.81% | -292.30% | -174.86% | -3.47% |
| Return on Equity (ROE) | 19.92% | 144.31% | 298.14% | 2260.20% | -5.34% |
| Return on Capital Employed (ROCE) | 15.81% | 126.22% | -4408.15% | -281.63% | -124.89% |
| Return on Invested Capital (ROIC) | 16.90% | 164.80% | -1506.33% | -247.41% | -121.70% |
| Return on Tangible Assets | -1409.51% | -478.36% | -296.16% | -174.86% | -3.47% |
| Earnings Yield | -87.69% | -177.25% | -283.85% | -173.89% | -7.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 58.01 | 2072.36 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.22 | 0.07 | 4.03 | 13.38 | 48.25 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 593.10 | 4.32 | 4.36 | 1.11 | 0.25 |
| Asset Turnover | 3.76 | 0.74 | 1.49 | 0.89 | 0.24 |
| Working Capital Turnover Ratio | -0.10 | -0.32 | -3.09 | -3.10 | 8.13 |
| Cash Conversion Cycle | -1616.11 | -5574.48 | -90.61 | -27.28 | -7.56 |
| Days of Sales Outstanding | 6.29 | 0.18 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1622.40 | 5574.66 | 90.61 | 27.28 | 7.56 |
| Operating Cycle | 6.29 | 0.18 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.16 | -0.94 | -1.53 | 0.03 |
| Free Cash Flow Per Share | -0.05 | -0.16 | -0.94 | -1.66 | -6.03 |
| Dividend Paid and CapEx Coverage Ratio | -38.11 | -417.18 | -2372.81 | -4.31 | 0.00 |
| Capital Expenditure Coverage Ratio | -38.11 | -417.18 | -2372.81 | -11.17 | 0.01 |
| Operating Cash Flow Coverage Ratio | -0.61 | -1.55 | -8.26 | -6.86 | 0.14 |
| Operating Cash Flow to Sales Ratio | -0.58 | -1.57 | -0.70 | -0.58 | 0.01 |
| Free Cash Flow Yield | -17.38% | -46.07% | -101.73% | -56.35% | -133.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.20 | -0.73 | -0.35 | -0.58 | -13.10 |
| Price-to-Sales (P/S) Ratio | 3.43 | 3.42 | 0.69 | 1.13 | 1.92 |
| Price-to-Book (P/B) Ratio | -0.23 | -0.81 | -1.05 | -13.00 | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.75 | -2.17 | -0.98 | -1.77 | -0.75 |
| Price-to-Operating Cash Flow Ratio | -5.90 | -2.18 | -0.98 | -1.93 | 133.63 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | 0.00 | 0.11 | -0.01 |
| Enterprise Value Multiple | -1.91 | -0.78 | -0.52 | -0.32 | 6.83 |
| Enterprise Value | 2.23M | 2.24M | 4.50M | 6.87M | 7.31M |
| EV to EBITDA | -1.91 | -0.78 | -0.52 | -0.32 | 6.83 |
| EV to Sales | 4.22 | 3.76 | 0.77 | 1.17 | 1.89 |
| EV to Free Cash Flow | -7.07 | -2.39 | -1.09 | -1.84 | -0.74 |
| EV to Operating Cash Flow | -7.25 | -2.39 | -1.09 | -2.00 | 131.74 |
| Tangible Book Value Per Share | -1.25 | -0.42 | -0.89 | -0.23 | 6.47 |
| Shareholders’ Equity Per Share | -1.27 | -0.44 | -0.88 | -0.23 | 6.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.08 | 0.10 | 1.33 | 2.61 | 2.36 |
| Net Income Per Share | -0.25 | -0.63 | -2.61 | -5.13 | -0.35 |
| Tax Burden | 1.05 | 1.22 | 1.00 | 1.00 | 0.02 |
| Interest Burden | 1.27 | 1.02 | 1.01 | 0.46 | 46.53 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.15 | 4.40 | 1.58 | 2.72 | 0.83 |
| Stock-Based Compensation to Revenue | 0.42 | 1.01 | 1.42 | 2.60 | 0.63 |
| Income Quality | 0.20 | 0.32 | 0.36 | 0.13 | -0.10 |
Currency in USD